TA-1504

**TA-1504** is a topical small-molecule combination gel being developed by Zedman Biopharma for **acne**. The company pipeline identifies the aryl hydrocarbon receptor as its intended target; however, publicly available pipeline information does not specify the individual active ingredients or the precise pharmacologic effect at the receptor. The pipeline position indicates Phase 2 development, although this phase assignment is inferred from the visual progress-bar position rather than explicitly labeled trial-stage text. ([thederma.com](https://www.thederma.com/en/science.html))

Other names

TA-1504 Combination GelTA1504 Combination GelTA 1504 Combination GelTA-1504 Compound GelTA1504 Compound GelTA 1504 Compound GelTA-1504 复方凝胶